nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Posterior subcapsular cataract—Prednisolone—chronic obstructive pulmonary disease	0.0766	0.0766	CcSEcCtD
Neomycin—Nerve injury—Prednisolone—chronic obstructive pulmonary disease	0.0543	0.0543	CcSEcCtD
Neomycin—Ulcerative keratitis—Prednisolone—chronic obstructive pulmonary disease	0.0469	0.0469	CcSEcCtD
Neomycin—Cataract subcapsular—Prednisolone—chronic obstructive pulmonary disease	0.0454	0.0454	CcSEcCtD
Neomycin—Nerve injury—Prednisone—chronic obstructive pulmonary disease	0.0394	0.0394	CcSEcCtD
Neomycin—Eye infection—Prednisolone—chronic obstructive pulmonary disease	0.0382	0.0382	CcSEcCtD
Neomycin—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.036	0.036	CcSEcCtD
Neomycin—Ulcerative keratitis—Prednisone—chronic obstructive pulmonary disease	0.0341	0.0341	CcSEcCtD
Neomycin—Cataract subcapsular—Prednisone—chronic obstructive pulmonary disease	0.033	0.033	CcSEcCtD
Neomycin—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.0291	0.0291	CcSEcCtD
Neomycin—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.0291	0.0291	CcSEcCtD
Neomycin—Impaired healing—Prednisolone—chronic obstructive pulmonary disease	0.0274	0.0274	CcSEcCtD
Neomycin—Viral infection—Arformoterol—chronic obstructive pulmonary disease	0.0242	0.0242	CcSEcCtD
Neomycin—Viral infection—Formoterol—chronic obstructive pulmonary disease	0.0242	0.0242	CcSEcCtD
Neomycin—Viral infection—Montelukast—chronic obstructive pulmonary disease	0.0237	0.0237	CcSEcCtD
Neomycin—Viral infection—Salbutamol—chronic obstructive pulmonary disease	0.0229	0.0229	CcSEcCtD
Neomycin—Impaired healing—Prednisone—chronic obstructive pulmonary disease	0.0199	0.0199	CcSEcCtD
Neomycin—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.0157	0.0157	CcSEcCtD
Neomycin—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0153	0.0153	CcSEcCtD
Neomycin—Viral infection—Prednisolone—chronic obstructive pulmonary disease	0.0131	0.0131	CcSEcCtD
Neomycin—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.0114	0.0114	CcSEcCtD
Neomycin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0113	0.0113	CcSEcCtD
Neomycin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0105	0.0105	CcSEcCtD
Neomycin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0103	0.0103	CcSEcCtD
Neomycin—Infection—Aminophylline—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Neomycin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00978	0.00978	CcSEcCtD
Neomycin—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00961	0.00961	CcSEcCtD
Neomycin—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.00953	0.00953	CcSEcCtD
Neomycin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00914	0.00914	CcSEcCtD
Neomycin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00781	0.00781	CcSEcCtD
Neomycin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00781	0.00781	CcSEcCtD
Neomycin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00776	0.00776	CcSEcCtD
Neomycin—Infection—Formoterol—chronic obstructive pulmonary disease	0.00776	0.00776	CcSEcCtD
Neomycin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00765	0.00765	CcSEcCtD
Neomycin—Infection—Montelukast—chronic obstructive pulmonary disease	0.0076	0.0076	CcSEcCtD
Neomycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00756	0.00756	CcSEcCtD
Neomycin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00737	0.00737	CcSEcCtD
Neomycin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00732	0.00732	CcSEcCtD
Neomycin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00726	0.00726	CcSEcCtD
Neomycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00713	0.00713	CcSEcCtD
Neomycin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00702	0.00702	CcSEcCtD
Neomycin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00684	0.00684	CcSEcCtD
Neomycin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00652	0.00652	CcSEcCtD
Neomycin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00615	0.00615	CcSEcCtD
Neomycin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00609	0.00609	CcSEcCtD
Neomycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00575	0.00575	CcSEcCtD
Neomycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00575	0.00575	CcSEcCtD
Neomycin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00575	0.00575	CcSEcCtD
Neomycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00563	0.00563	CcSEcCtD
Neomycin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00552	0.00552	CcSEcCtD
Neomycin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00552	0.00552	CcSEcCtD
Neomycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00543	0.00543	CcSEcCtD
Neomycin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00541	0.00541	CcSEcCtD
Neomycin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00534	0.00534	CcSEcCtD
Neomycin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00534	0.00534	CcSEcCtD
Neomycin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00523	0.00523	CcSEcCtD
Neomycin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00522	0.00522	CcSEcCtD
Neomycin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00518	0.00518	CcSEcCtD
Neomycin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00504	0.00504	CcSEcCtD
Neomycin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00496	0.00496	CcSEcCtD
Neomycin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00496	0.00496	CcSEcCtD
Neomycin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Neomycin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Neomycin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Neomycin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Neomycin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Neomycin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00438	0.00438	CcSEcCtD
Neomycin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00423	0.00423	CcSEcCtD
Neomycin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00376	0.00376	CcSEcCtD
Neomycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Neomycin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Neomycin—Infection—Prednisone—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Neomycin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Neomycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00226	0.00226	CcSEcCtD
Neomycin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Neomycin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Neomycin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Neomycin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
